Covered recipient · General Payments record
SHANNON ANN THOMA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$159.53
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.53 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $29.24 | 2 |
| Amgen Inc. | $27.18 | 1 |
| Janssen Pharmaceuticals, Inc | $23.18 | 1 |
| TG THERAPEUTICS, INC. | $22.74 | 1 |
| PFIZER INC. | $22.41 | 1 |
| Merck Sharp & Dohme Corporation | $20.84 | 1 |
| GENZYME CORPORATION | $13.94 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $159.53 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $27.18 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117397956 | CMS |
| GENZYME CORPORATION | $13.94 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139840467 | CMS |
| Janssen Pharmaceuticals, Inc | $23.18 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078000680 | CMS |
| Merck Sharp & Dohme LLC | $20.84 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141658102 | CMS |
| PFIZER INC. | $22.41 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131679081 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.16 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137833289 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.08 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137833291 | CMS |
| TG Therapeutics, Inc. | $22.74 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136879264 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.